EP Patent

EP2659834A1 — Costoptimized Hp capsule

Assigned to Siemens AG · Expires 2013-11-06 · 13y expired

What this patent protects

The invention relates to a method for producing an ingestible capsule, comprising at least two electrodes 3 affixed to a substrate 1 being embedded in a resin material 13, wherein at least a portion of each electrode 3 is exposed. The capsule can be used to detect Helicobacter py…

USPTO Abstract

The invention relates to a method for producing an ingestible capsule, comprising at least two electrodes 3 affixed to a substrate 1 being embedded in a resin material 13, wherein at least a portion of each electrode 3 is exposed. The capsule can be used to detect Helicobacter pylori (Hp).

Drugs covered by this patent

Patent Metadata

Patent number
EP2659834A1
Jurisdiction
EP
Classification
—
Expires
2013-11-06
Drug substance claim
No
Drug product claim
No
Assignee
Siemens AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.